/ - \
Home
-Experience - Innovation - Persistence
SBH 17 Years!The World's Leading Provider of Cytokine Cell-Based Assays
-

SBH Sciences News

SBH 17 Years!

January 27, 2014
Galectin Therapeutics Inc. and SBH Sciences, Inc. Announce the Formation of Galectin Sciences, LLC, a Collaborative Venture to Research and Develop Galectin Inhibitors for Oral Administration

October 25, 2013
SBH Sciences and Reinnervate are offering Alvetex® introductory 3D tumor cell screening services

August 6, 2013
SBH Sciences - News Q3, 2013

July 15, 2013
ZF BIOTOX and SBH Sciences Join forces to offer Cell in Well™ service to the US Biotech Industry

April 4, 2013
Procognia and SBH Sciences Join forces to Offer Services to Biotech Industry

October 10, 2012
Woodland and SBH Sciences Announce New Incubator Model to support IND-enabling Preclinical Efficacy Studies for Novel Oncology Molecules

August,31, 2012
Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA, while maintaining the excellent work being done by our Collaborators at SBH Sciences.
NEWTON, MA Aug. 31, 2012 Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA while the Boston area location will continue product development and analysis, cell culture models of drug action and the development of analytical tools for complex carbohydrate drugs. The Boston area laboratory effort will be located at SBH Sciences in Natick, MA, where the Company has had a long-term relationship, and will be led by Dr. Eliezer Zomer, the Senior Vice President for Manufacturing and Development. Read full press release

August,27, 2012
SBH Sciences Celebrates its 15-Year Anniversary

August,22, 2012
A Full Spectrum Of Preclinical Oncology Services is Enabled by the New Strategic Partnership of SBH Sciences and Woodland Oncology Services.

June 19, 2012
Governor Patrick and Israeli Chief Scientist Avi Hasson Announce First Round of Massachusetts-Israel Innovation Partnership Grants at Biotechnology Industry Organization (BIO) Convention

Video and Text of the speech given by Raphael Nir, President of SBH Sciences, during the Massachusetts-Israel Innovation Partnership (MIIP) event.

Raphael Nir- President of SBH Sciences

June 14-18, 2012
COVIDIEN, Organix and SBH Sciences are presenting a poster in World Congress of Interventional Oncology (WCIO)

April 30, 2012
SBH Sciences and Cell Assay Innovations Announce an Agreement to Provide Kinase Cell-based Screening Services

October 24, 2011
SBH Sciences Registered with CLIA

December 18, 2009
pION Biopharma Services & SBH Sciences Announces Caco-2 Permeability Measurement


 


-
- - -


The World's Leading Provider of Cytokine Cell-Based Assays

/ - \